All our lecturers have different academic profiles. Making contact with them and joining discussions is a unique feature of the Hessen International Summer University.

Dr. Adam Andrzejewski

Adam Andrzejewski is Assistant Professor at the Kozminski University in Poland, where he teaches in the Law School, offering classes in Comparative Corporate Law, International Economic Law, and Intellectual Property Law. He has also offered a course in International Intellectual Property Law at the Chile Summer Program in Santiago. Dr. Andrzejewski is also a practicing attorney-at-law. 

Adam Andrzejewski completed his legal education at the universities of Warsaw in Poland and Cologne in Germany. He graduated with distinction in 2007 and holds a law degree (J.D. equivalent). From 2008 to 2011, he was a research associate at the Institute for Public, European and Public International Law at Justus Liebig University, Giessen. He earned his Doctor juris (S.J.D. equivalent) from the University of Giessen in 2013. His doctoral thesis, supervised by Prof. Dr. Thilo Marauhn, was on patent auctions as an alternative business structure for intellectual property assets acquisition and sales. He received a scholarship from the federal state of Hessen for his research in Giessen and at Max Planck Institute in Munich. Throughout his preparation of his doctoral thesis Dr. Andrzejewski was supported by a scholarship from the Hesse, a federal state of Germany.

Following his legal education, Dr. Andrzejewski cooperated with GlaxoSmithKline Pharmaceuticals in Warsaw and Ernst & Young in Dublin. He also worked as an attorney-at-law in the Intellectual Property and Technology department of DLA Piper in Warsaw. 

His main research interests focuses on corporate governance in different jurisdictions, international trade law, European law, and intellectual property rights. In his private practice he has specialized in corporate law, mergers & acquisitions and intellectual property law. He advises national and international corporate clients.

Dr. Barbara Ann Hocking

Barbara Ann Hocking completed her undergraduate legal education at Monash University in Melbourne, followed by her post-graduate studies at both University of Stockholm and University of London. Afterwards, she wrote her PhD thesis at the University of Queensland School of Law on the topic of criminal conspiracy. In 2007, while working as an academic at Queensland University of Technology Faculty of Law in Brisbane, Barbara Ann was awarded an Australian Research Council International Fellowship. She was awarded this fellowship in partnership with several colleagues, including some from Giessen University, to work on pandemic planning and benefit-sharing of vaccines, with a particular focus on the human rights implications of legal developments in these areas. The legacy of that project brings Barbara Ann to Giessen each year to contribute to the ISU.

Dr. Jafargholi Imani

Jafargholi Imani works as a scientific group leader at the Institute for Phytopathology & Applied Zoology (JLU Giessen). He graduated in Agricultural Science and is continuously involved in scientific work on Plant Tissue Culture & Genetic Transformation of several plant species. In addition to teaching students of international master programms in Agro-Biotechnology, he leads scientific projects e.g. "BioSafety in transgenic research under glasshouse and field condition”.

Additionally, Jafargholi Imani is a member of numerous associations such as Arbeitskreis “Deutsche In Vitro Kulturen e.V.” (ADIVK), International Association for Plant Tissue Culture & Biotechnology (IAPTC&B), and "Gesellschaft für Pflanzenbiotechnologie e.V.". He also acts as a consultant at the EU Marie Curie Chair, Universidade de Évora, Portugal.

He published the result of his research in various international high impact factor journals. Recently, he published a scientific book (2009, Springer-Verlag) together with his former collegues Prof. Neumann and Prof. Kumar. This book provides a general introduction as well as a selected survey of key advances in the fascinating field of plant cell and tissue culture as a tool in biotechnology.

Dr. Daniel Kuhn

Daniel Kuhn is currently working as a computational chemist and discovery project leader at Merck in Darmstadt, Germany. He obtained his PhD from Philipps-University, Marburg in computational chemistry working with Gerhard Klebe on the classification of protein binding sites. In 2004 he joined Boehringer Ingelheim in Vienna as a computational chemist working in oncology research. In 2010 he joined Merck as senior scientist contributing to projects in early and late drug discovery stages. He is also leading a lead optimization project towards preclinical development. His research interests include protein kinase drug discovery, structure-based design and knowledge-driven approaches to hit identification and lead-optimization.

Prof. Dr. Jürgen Meckl

Jürgen Meckl is Professor of International Economics at the University of Giessen and research fellow of the Institute for the Study of Labor, Bonn. He conducted his studies in economics at the University of Regensburg (diploma) and at the University of Konstanz (PhD and habilitation). He was visiting professor at the University of Wisconsin/Milwaukee, and at the University of Nottingham, among other universities. He was Dean of the Faculty of Economics and Business Studies in Giessen and is the coordinator of the Milwaukee-Giessen student exchange program. His research interests are in the fields of international trade, human-capital accumulation and economic growth, macroeconomics of structural change and labor economics.

Prof. Meckl has published several articles in leading academic journals of his field (e.g. American Economic Review, Economic Journal, Economic Theory). He has been awarded various prizes for his research and for his excellence in teaching (Lehrpreis des Landes Baden Württemberg, 1999).

Prof. MD. Markus Meyer

Markus Meyer is Professor at Hannover Medical School and Chief Development Officer at Cardiorentis. He graduated in medicine (licence to practice medicine) and scientifically worked on natriuretic peptides. Later, he co-founded Biotech companies. One of them developed a peptide up to clinical proof of concept through Phase II b and then out-licensed it. Meyer then held a position as Chief Medical Officer in a company which developed drug candidates up to clinical proof of concept in Phase II.

Currently, he is Chief Development Officer at Cardiorentis, which purchased the global licence of the peptide he worked on in the beginning of his career. For the time being, Cardiorentis is conducting a pivotal Phase III trial in the EU, the US and South America to seek approval for the first drug against acute decompensated heart failure in 2015.

Dr. Christian Obermeier

Christian Obermeier is a postdoc working at the Insitute for Plant Breeding at Justus Liebig University Giessen. He graduated in biology at the Technical University in Braunschweig and has been working at the U.S. Department of Agriculture as well as at the Horticulture Research International, UK on the molecular characterization of plant virus diseases and plant-pathogen interaction using biotechnological approaches.

In Giessen he is studying gene expression and disease resistance in oilseed rape using high-throughput metabolomic and next generation sequencing-based transcriptome, genome and marker analysis techniques.

Dr. Arno Risse, LL.M. (Auckland)

Arno is a German lawyer and bar-certified specialist attorney for intellectual property law specialized on patent litigation. He is a Counsel with the IP specialized law firm Arnold Ruess in Düsseldorf. Before joining the Arnold Ruess team, he was working from 2010 to 2015 as an Associate and Principal Associate in the intellectual property and information technology practice group of Freshfields Bruckhaus Deringer. Arno teaches European Patent Law at the International Summer University Giessen (since 2015) and speaks at national and international patent law conferences. 

Arno graduated from the Westfälische Wilhelms-Universität in Münster and holds a Master's degree in commercial law (LL.M.) from the University of Auckland, New Zealand. He published a Ph.D. thesis on contract law. 

Prof. Dr. Monika Schuhmacher

Monika Schuhmacher is Professor of Technology, Innovation and Entrepreneurship at the University of Giessen. She is also Director of the Entrepreneurship Cluster Central Hesse at the University of Giessen. In the past, Monika Schuhmacher taught at the University of Mannheim, Mannheim Business School, Copenhagen Business School (Denmark) and the ESSEC Graduate School (France). Monika Schuhmacher conducted her studies at the University of Mannheim (diploma, PhD and habilation) and the University of North Carolina, Greensboro (M.B.A.).Her research interests are in the fields of technology and innovation management and -marketing, open innovation, reverse innovation, business model innovation, internet of things, and entrepreneurial marketing. Her teaching focus is primarily located in the areas of strategic technology and innovation management, innovation marketing, entrepreneurship, marketing management and global marketing. Prof. Schuhmacher has published articles in the International Journal of Research in Marketing, Journal of Product Innovation Management or Creativity & Innovation Management.